Open

Announcement of Collaborative Research Agreement for Creating a Solution to Predict Systemic Diseases from Eye Health Information

Management

R&D

ROHTO Pharmaceutical Co., Ltd. Continues to Provide New Solutions in Eye Care, Venturing into New Values, Products, and Businesses in the Healthcare Sector Announcement of Collaborative Research Agreement for Creating a Solution to Predict Systemic Diseases from Eye Health Information

Sep 7, 2021

ROHTO Pharmaceutical Co., Ltd. (Head Office: Osaka City, Osaka, President: Masashi Sugimoto) is pleased to announce that it has entered into a collaborative research agreement with the Department of Neural and Sensory Organ Surgery Ophthalmology at the Graduate School of Medicine, Osaka University (Professor Kohji Nishida), and SAI Co., Ltd. (Representative Director t: Yasufumi Fukuma), aimed at creating a new solution to enhance overall health based on eye information. The agreement was reached today.

Background and Objectives of the Research

In recent years, diagnostic devices in the field of ophthalmology have advanced significantly, enabling multifaceted information gathering. Additionally, new reports have highlighted distinctive changes in the eyes associated with systemic diseases. This means that state-of-the-art ophthalmic diagnostic equipment can be used not only for eye care but also for evaluating overall health conditions.
By integrating eye health information with regular health checkup data and lifestyle survey data, it is expected that we can predict and diagnose the onset of diseases at an early stage and assess one's health status before diseases manifest.
Leveraging the knowledge and diagnostic techniques in ophthalmology at Osaka University's Graduate School of Medicine, SAI's expertise in information science, and their unique AI analysis technology, along with ROHTO Pharmaceutical's cohort data and product/business development capabilities, we will collaborate to create new healthcare initiatives such as personalized medicine and preventive medicine.
Through this collaboration among the three parties, we aim to realize early prediction and diagnosis of disease onset, fostering the innovation of preventing these diseases. This will contribute to extending healthy lifespans and realizing a society where everyone can stay healthy and active throughout their centenary lives.

Figure: Role image of the three